NCT04258631View on ClinicalTrials.gov

Liposomal Bupivacaine With or Without Hydromorphone for the Improvement of Pain Control After Laparotomy in Patients With Gynecological Malignancies

PHASE4CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

July 9, 2020

Primary Completion Date

August 8, 2023

Study Completion Date

August 8, 2023

Conditions
Malignant Female Reproductive System Neoplasm
Interventions
DRUG

Hydromorphone

Given IT

PROCEDURE

Laparotomy

Undergo laparotomy

DRUG

Liposomal Bupivacaine

Drug

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04258631 - Liposomal Bupivacaine With or Without Hydromorphone for the Improvement of Pain Control After Laparotomy in Patients With Gynecological Malignancies | Biotech Hunter | Biotech Hunter